Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2014

01-07-2014 | Original Article

Utility of the “Harmless Acute Pancreatitis Score” in predicting a non-severe course of acute pancreatitis: A pilot study in an Indian cohort

Authors: Rupjyoti Talukdar, Mithun Sharma, Ajit Deka, Sultana Teslima, Amal Dev Goswami, Arunima Goswami, Anup Baro, D. Nageshwar Reddy

Published in: Indian Journal of Gastroenterology | Issue 4/2014

Login to get access

Abstract

Background

Several severity predictors have been tested for assessing acute pancreatitis (AP). The recently described harmless acute pancreatitis score (HAPS) could be an ideal predictor for Indian patients at the community level. We validate this system in the current study.

Methods

This was a prospective pilot study conducted at a tertiary center from July 2010 to December 2011. Consecutive directly admitted patients over 18 years with a documented first episode of AP were enrolled and followed for at least 12 months after discharge/till death. HAPS was defined as absence of rebound abdominal tenderness, serum creatinine of <2 mg/dL, and hematocrit of <43 for male and <39.6 for female patients at the time of admission; and it was considered positive if the patient fulfilled all three criteria. Study outcomes included total hospital stay, need for intensive care unit (ICU), ICU stay, development of local complications, organ failure, hospital-acquired infections (including infected necrosis), and in-hospital mortality.

Results

There were a total of 103 patients directly admitted with AP during the study period, out of which, 23 were excluded. Forty-seven (58.8 %) patients were positive for HAPS. Of these, 44 (93.6 %) had an eventual non-severe (mild) clinical course with odds ratio 17.6 (95 % CI 4.5–68.3). Sensitivity, specificity, positive and negative predictive value, and receiver operating characteristics area under the curve of HAPS as a predictor of non-severe disease were 76.3 (66.9–86.4), 85.7 (78.0–96.8), 93.8 (88.5–98.6), 56.6 (45.4–73.6), and 84.8 (76.9–92.7) respectively.

Conclusion

This study validated the utility of HAPS for directly admitted patients with AP in India. Large-scale multicenter community-based studies need to be performed.
Literature
1.
go back to reference Talukdar R, Nageshwar Reddy D. Predictors of adverse outcomes in acute pancreatitis: new horizons. Indian J Gastroenterol. 2013;32:143–51.PubMedCrossRef Talukdar R, Nageshwar Reddy D. Predictors of adverse outcomes in acute pancreatitis: new horizons. Indian J Gastroenterol. 2013;32:143–51.PubMedCrossRef
2.
go back to reference Talukdar R, Nechutova H, Clemens M, Vege SS. Could rising BUN predict the future development of infected pancreatic necrosis? Pancreatology. 2013;13:355–9.PubMedCrossRef Talukdar R, Nechutova H, Clemens M, Vege SS. Could rising BUN predict the future development of infected pancreatic necrosis? Pancreatology. 2013;13:355–9.PubMedCrossRef
3.
go back to reference Wu BU, Johannes RS, Sun X, et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology. 2009;137:129–35.PubMedCrossRef Wu BU, Johannes RS, Sun X, et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology. 2009;137:129–35.PubMedCrossRef
4.
go back to reference Wu BU, Bakker OJ, Papachristou GI, et al. Blood urea nitrogen in early assessment of acute pancreatitis: an international validation study. Arch Intern Med. 2011;171:669–76.PubMedCrossRef Wu BU, Bakker OJ, Papachristou GI, et al. Blood urea nitrogen in early assessment of acute pancreatitis: an international validation study. Arch Intern Med. 2011;171:669–76.PubMedCrossRef
5.
go back to reference Lankisch PG, Weber-Dany B, Maisonneuve P, et al. The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease. Clin J Gastroenterol. 2009;7:702–5.CrossRef Lankisch PG, Weber-Dany B, Maisonneuve P, et al. The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease. Clin J Gastroenterol. 2009;7:702–5.CrossRef
6.
go back to reference Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–45.PubMedCrossRef Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–45.PubMedCrossRef
8.
go back to reference Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.PubMedCrossRef Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.PubMedCrossRef
9.
go back to reference Bradley EL 3rd. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA September 11–13, 1992. Arch Surg. 1993;128:586–90.PubMedCrossRef Bradley EL 3rd. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA September 11–13, 1992. Arch Surg. 1993;128:586–90.PubMedCrossRef
10.
go back to reference Oskarsson V, Mehrabi M, Orsini N, et al. Validation of the harmless acute pancreatitis score in predicting nonsevere course of acute pancreatitis. Pancreatology. 2011;11:464–8.PubMedCrossRef Oskarsson V, Mehrabi M, Orsini N, et al. Validation of the harmless acute pancreatitis score in predicting nonsevere course of acute pancreatitis. Pancreatology. 2011;11:464–8.PubMedCrossRef
11.
go back to reference Gardner TB. Use the harmless acute pancreatitis score wisely. Clin Gastroenterol Hepatol. 2009;7:1378. Gardner TB. Use the harmless acute pancreatitis score wisely. Clin Gastroenterol Hepatol. 2009;7:1378.
Metadata
Title
Utility of the “Harmless Acute Pancreatitis Score” in predicting a non-severe course of acute pancreatitis: A pilot study in an Indian cohort
Authors
Rupjyoti Talukdar
Mithun Sharma
Ajit Deka
Sultana Teslima
Amal Dev Goswami
Arunima Goswami
Anup Baro
D. Nageshwar Reddy
Publication date
01-07-2014
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2014
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-014-0452-4

Other articles of this Issue 4/2014

Indian Journal of Gastroenterology 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.